Cue Biopharma, Inc. (CUE) Ownership

NASDAQ: CUETop holders, insider trades and short interest.

CUE ownership summary

as of October 17, 2026
Institutions
22.8%
of shares outstanding
Insiders
15.05%
of shares outstanding
Shares outstanding
7.3M
Float
6.4M
shares available to trade
Short interest
10.15%
702K shares short
Days to cover
1.70
short interest up 111.4% vs prior month
  • Institutions 22.80%
  • Insiders 15.05%
  • Other investors 62.15%

CUE top institutional holders

20 largest
Cue Biopharma, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Bleichroeder LP5.10%371K$6.2M+143,399 (+63.1%)June 30, 2026
2Driehaus Capital Management LLC4.02%292K$4.9M+292,144 (0.0%)June 30, 2026
3Vanguard Capital Management, LLC2.23%162K$2.7M+79,793 (+97.4%)June 30, 2026
4Ikarian Capital, LLC1.44%104K$1.7M+104,364 (0.0%)June 30, 2026
5Polygon Management Ltd1.29%94K$1.6M+93,819 (0.0%)June 30, 2026
6StemPoint Capital LP0.92%67K$1.1M+66,995 (0.0%)June 30, 2026
7BlackRock Inc0.80%58K$965,955+42,836 (+286.1%)June 30, 2026
8ADAR1 Capital Management LLC0.76%55K$922,275+55,193 (0.0%)June 30, 2026
9Lion Point Capital, LP0.73%53K$884,427−20,493 (−27.9%)June 30, 2026
10Squadron Capital Management LLC0.69%50K$835,500+50,000 (0.0%)June 30, 2026
11Diadema Partners LP0.67%48K$808,246+43,970 (+999.5%)June 30, 2026
12Geode Capital Management, LLC0.66%48K$799,139+12,338 (+34.8%)June 30, 2026
13BOOTHBAY FUND MANAGEMENT, LLC0.43%31K$525,680+31,459 (0.0%)June 30, 2026
14UBS Group AG0.37%27K$446,157+23,755 (+806.6%)June 30, 2026
15Citadel Advisors Llc0.35%26K$428,327+25,633 (0.0%)June 30, 2026
16Vanguard Fiduciary Trust Co0.34%24K$408,994+6,358 (+35.1%)June 30, 2026
17Texas Capital Bank Wealth Management Services Inc0.32%23K$382,342+9,635 (+72.7%)June 30, 2026
18Renaissance Technologies Corp0.20%15K$245,453+7,562 (+106.1%)June 30, 2026
19State Street Corp0.20%14K$236,881+8,198 (+137.1%)June 30, 2026
20Persistent Asset Partners Limited0.17%12K$206,068+11,220 (+1,009.0%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 19 holders added 1.1M shares and 1 cut 20K.

CUE top mutual fund and ETF holders

13 largest
Cue Biopharma, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Vanguard MStar Total Stk Mkt Idx Invest1.54%112K$1.9M—August 31, 2026
2BSF Systematic US Eq Abs Ret A2 USD0.01%31K$520,015—December 31, 2025
3Fidelity Extended Market Index0.28%21K$342,856+676 (+3.4%)August 31, 2026
4iShares Micro-Cap ETF0.12%8,698$145,344−60 (−0.7%)September 30, 2026
5Fidelity Total Market Index0.10%7,431$124,172+178 (+2.5%)August 31, 2026
6Fidelity Series Total Market Index0.09%6,340$105,941+393 (+6.6%)August 31, 2026
7Vanguard Balanced Index Inv0.02%1,724$28,808—August 31, 2026
8Vanguard U.S. Eq Idx £ Acc0.02%1,637$27,354—August 31, 2026
9Vanguard MStar Inst Ttl StkMktIdxInstlPl0.01%1,019$17,027—August 31, 2026
101290 VT Micro Cap K0.01%747$12,482—August 31, 2026
11Avantis US Small Cap Equity ETF<0.01%301$5,030—September 30, 2026
12DFA US Micro Cap I<0.01%105$1,755—August 31, 2026
13JHVIT Total Stock Market Index I<0.01%73$1,220+14 (+23.7%)August 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

CUE insider transactions

latest 3
Cue Biopharma, Inc. insider transactions
DateNameTransactionPriceSharesValue
2024-12-16Daniel R PasseriBuy$30.901,000$30,900
2023-08-25Anish SuriBuy$82.80133$11,012
2023-08-14Daniel R PasseriBuy$85.80100$8,580

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

CUE shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns CUE

Institutional investors own 22.8% of Cue Biopharma's shares and insiders 15.05%. The largest holder is Bleichroeder LP with 5.10% of the shares (371K), as of June 30, 2026. Among the top 20 institutions, 19 added shares and 1 reduced their stake in the latest filings. Short interest is 10.15% of the float, or 1.70 days of average trading volume. The share count rose 435.4% since 2016.

Related: CUE analyst forecast, CUE key metrics. See the CUE stock overview for the latest quote and news.

CUE ownership FAQ

Who owns the most Cue Biopharma stock?

The largest shareholders of Cue Biopharma are Bleichroeder LP (5.10%), Driehaus Capital Management LLC (4.02%), Vanguard Capital Management, LLC (2.23%), Ikarian Capital, LLC (1.44%), Polygon Management Ltd (1.29%).

What percentage of Cue Biopharma is owned by institutions?

Institutions hold 22.8% of Cue Biopharma's shares outstanding; insiders hold 15.05%.

Which funds own Cue Biopharma?

The largest fund holders of Cue Biopharma are Vanguard MStar Total Stk Mkt Idx Invest (1.54%), BSF Systematic US Eq Abs Ret A2 USD (0.01%), Fidelity Extended Market Index (0.28%), iShares Micro-Cap ETF (0.12%), Fidelity Total Market Index (0.10%).

What is Cue Biopharma's short interest?

702K shares of Cue Biopharma were sold short, 10.15% of the float; at the average daily volume it would take 1.70 days to cover.

Are insiders buying or selling Cue Biopharma?

Of the latest 3 reported insider transactions in Cue Biopharma (since August 14, 2023), 3 were purchases and 0 were sales.

How many shares of Cue Biopharma are outstanding?

Cue Biopharma has 7.3M shares outstanding, of which 6.4M are in the public float.

Biotechnology: ownership